Mirtazapine

Primary Use

Mirtazapine is a prescription antidepressant used to treat major depressive disorder. It works by affecting the balance of chemicals in the brain that regulate mood.

How It Works in Treatment

This medication is intended to help improve symptoms associated with depression, including:

• Persistent feelings of sadness or hopelessness.
• Loss of interest in daily activities.
• Changes in appetite or sleep patterns.

Mirtazapine is often prescribed when other antidepressant treatments have not provided sufficient relief or when a healthcare provider determines it is the most appropriate option for a patient's specific needs. It is usually taken daily, and it may take several weeks of regular use before the full therapeutic effects are noticed.

How Mirtazapine Works

Mirtazapine belongs to a class of medications known as tetracyclic antidepressants. While the exact way it works is not fully understood, it is believed to help the brain maintain a better balance of certain chemicals called neurotransmitters. These chemicals, specifically norepinephrine and serotonin, are involved in regulating mood, sleep, and appetite.

The medication is thought to improve symptoms of depression through the following actions in the central nervous system:

• Increasing chemical release: Mirtazapine blocks specific receptors in the brain called alpha-2 adrenergic receptors. These receptors normally act as a braking system to limit the release of norepinephrine and serotonin. By blocking these receptors, the medication allows more of these chemicals to be released into the brain.
• Targeting specific receptors: It also blocks certain types of serotonin receptors (specifically 5-HT2 and 5-HT3). This helps focus serotonin activity on the receptors that are most beneficial for improving mood, while potentially reducing certain side effects like nausea or anxiety.

By enhancing the activity of these neurotransmitters, mirtazapine helps restore chemical communication in the brain, which can lead to an improvement in mood and a reduction in the symptoms of depression.

Common Side Effects

Mirtazapine often causes side effects that are mild and may improve as your body adjusts to the medication. Common effects include:

• Drowsiness or sleepiness
• Increased appetite and weight gain
• Dry mouth
• Constipation
• Dizziness
• Feeling weak or tired

Serious Side Effects

Contact your doctor immediately or seek emergency care if you experience any of the following:

• Signs of an allergic reaction, such as a rash, hives, or swelling of the face, lips, or throat
• Flu-like symptoms, including fever, chills, sore throat, or mouth sores
• Chest pain or a fast, pounding, or irregular heartbeat
• Seizures
• Severe dizziness or fainting
• Yellowing of the skin or eyes
• Unusual bruising or bleeding
• Confusion, headache, or severe weakness

In rare cases, this medication can cause serotonin syndrome, a life-threatening condition. Seek immediate medical help for symptoms such as agitation, hallucinations, shivering, excessive sweating, muscle stiffness, or loss of coordination.

Suicidal Thoughts and Behaviors

Antidepressants may increase the risk of suicidal thinking and behavior in children, adolescents, and young adults. Families and caregivers should monitor for worsening depression, irritability, or unusual changes in behavior, especially during the first few months of treatment or after dose changes.

Serious Blood Disorders

Mirtazapine has been associated with agranulocytosis, a severe reduction in white blood cells that can lead to serious infections. Medical attention is necessary if symptoms such as fever, chills, sore throat, or mouth sores develop.

Serotonin Syndrome

A potentially life-threatening condition called serotonin syndrome may occur, particularly when mirtazapine is taken with other medications that affect serotonin levels. Symptoms include agitation, hallucinations, rapid heart rate, dizziness, sweating, and muscle stiffness.

Drug Interactions and Contraindications

• MAOIs: Mirtazapine must not be used with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI due to the risk of severe reactions.
• Linezolid or Methylene Blue: Treatment should not be started in patients receiving intravenous methylene blue or linezolid.

Heart Rhythm Changes

This medication can cause QT prolongation, a condition affecting the heart's electrical rhythm. The risk is higher for individuals with existing heart conditions, electrolyte imbalances, or those taking other medications that affect the heart rhythm.

Other Precautions

• Angle-Closure Glaucoma: Mirtazapine may trigger an acute glaucoma attack in people with anatomically narrow angles who do not have a protective procedure.
• Cholesterol and Weight: Increases in appetite, weight gain, and elevated cholesterol or triglyceride levels are common.
• Sedation: Significant drowsiness may occur, which can impair the ability to drive or operate machinery.
• Discontinuation: Stopping the medication abruptly can cause withdrawal symptoms. A gradual reduction in dose is typically recommended.

Pregnancy

There are no adequate and well-controlled studies of mirtazapine use in pregnant women. Animal studies have shown some evidence of increased pregnancy loss and decreased pup survival at doses much higher than human doses. Because of the lack of human data, mirtazapine should be used during pregnancy only if clearly needed and after a discussion with a healthcare provider about the potential risks and benefits.

If you become pregnant while taking this medication, notify your doctor immediately. Do not stop taking the medication without consulting your healthcare provider, as untreated depression can also pose risks to both the parent and the baby.

Breastfeeding

It is not known whether mirtazapine passes into human breast milk. Many medications are excreted in milk, and the effects on a nursing infant are not well understood. Healthcare providers typically recommend weighing the benefits of breastfeeding against the potential risks to the infant or the benefits of the medication to the mother.

If you are breastfeeding or planning to breastfeed, talk to your doctor to determine the safest course of action for your specific situation.

Available Forms

Mirtazapine is provided in two primary oral formulations:

• Oral Tablets: Conventional tablets that are swallowed whole.
• Orally Disintegrating Tablets: Tablets designed to dissolve rapidly on the tongue. These can be swallowed with or without water and are often used by individuals who have difficulty swallowing standard pills.

FDA Approval and Indications

Mirtazapine was approved by the U.S. Food and Drug Administration (FDA) in 1996. It is indicated for the treatment of major depressive disorder in adults.

Boxed Warning

Mirtazapine carries a boxed warning regarding the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24. This warning applies to all antidepressant medications. Patients of all ages who start antidepressant therapy should be monitored closely for worsening of symptoms or emergence of suicidal thoughts.

Regulatory Status

• Legal Status: Mirtazapine is a prescription medication and is not a controlled substance.
• Formulations: The FDA has approved mirtazapine in several forms, including oral tablets and orally disintegrating tablets.
• Pediatric Use: The FDA has not approved mirtazapine for use in pediatric patients.

Understanding Mirtazapine Withdrawal

If you stop taking mirtazapine abruptly, you may experience withdrawal symptoms, sometimes referred to as antidepressant discontinuation syndrome. These symptoms occur because your body needs time to adjust to the absence of the medication.

Common Withdrawal Symptoms

Symptoms of withdrawal can vary from person to person but often include:

• Dizziness and lightheadedness
• Nausea or vomiting
• Anxiety, agitation, or irritability
• Headaches
• Fatigue or tiredness
• Sleep disturbances, such as vivid dreams or insomnia
• Sensory changes, such as tingling or pins and needles sensations
• Sweating and tremors
• Confusion

How to Safely Stop Treatment

To reduce the risk of withdrawal symptoms, healthcare providers typically recommend gradually lowering the dose over a period of time. This process, known as tapering, allows your system to adapt slowly. You should never stop taking mirtazapine or change your dosage without first discussing a plan with your doctor. If symptoms become severe while tapering, your doctor may adjust the schedule to a slower pace.